美国及各州加强对阿片类药物危机的应对：运用监管、立法及法律手段。
U.S. and States Ramp Up Response to Opioid Crisis: Regulatory, Legislative, and Legal Tools Brought to Bear.
作者信息
Barlas Stephen
出版信息
P T. 2017 Sep;42(9):569-592.
Abstract
Politicians in both parties and at all levels of government have raised what many call the opioid crisis to a level of public attention it has never seen before. This article reviews the approaches, including prevention, treatment, and medication-assisted therapy, being taken by federal and state authorities to combat the abuse of opioids.
摘要
两党以及各级政府的政客们已将许多人所称的阿片类药物危机提升到了前所未有的公众关注程度。本文回顾了联邦和州当局为打击阿片类药物滥用所采取的方法，包括预防、治疗和药物辅助治疗。
相似文献
1
2
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
3
The US Opioid Crisis: Current Federal and State Legal Issues.美国阿片类药物危机：当前联邦和州的法律问题。
Anesth Analg. 2017 Nov;125(5):1675-1681. doi: 10.1213/ANE.0000000000002403.
4
Evaluation of US Federal Legislation for Opioid Abuse: 1973-2016.美国联邦阿片类药物滥用立法评估：1973 - 2016年
J Pain Palliat Care Pharmacother. 2016 Sep;30(3):218-24. doi: 10.1080/15360288.2016.1211213. Epub 2016 Sep 1.
5
Opioid Abuse Prevention and Treatment: Lessons From South Carolina.阿片类药物滥用的预防与治疗：来自南卡罗来纳州的经验教训
J Public Health Manag Pract. 2019 May/Jun;25(3):221-228. doi: 10.1097/PHH.0000000000000894.
6
Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.注射器服务项目：在美国阿片类药物危机不断演变的背景下对法律、政策和资金障碍的考察
Int J Drug Policy. 2019 Aug;70:22-32. doi: 10.1016/j.drugpo.2019.04.006. Epub 2019 May 3.
7
Government Legislation in Response to the Opioid Epidemic.政府应对阿片类药物泛滥的立法。
Curr Pain Headache Rep. 2019 May 1;23(6):40. doi: 10.1007/s11916-019-0781-1.
8
Opioids with abuse-deterrent properties: A regulatory and technological overview.具有滥用威慑特性的阿片类药物：监管与技术概述。
J Opioid Manag. 2017 Nov/Dec;13(6):397-413. doi: 10.5055/jom.2017.0417.
9
How States Are Tackling the Opioid Crisis.各州如何应对阿片类药物危机。
Public Health Rep. 2017 Mar/Apr;132(2):171-179. doi: 10.1177/0033354916688206. Epub 2017 Feb 2.
10
The opioid crisis: Origins, trends, policies, and the roles of pharmacists.阿片类药物危机：起源、趋势、政策以及药剂师的作用。
Am J Health Syst Pharm. 2019 Mar 19;76(7):424-435. doi: 10.1093/ajhp/zxy089.
引用本文的文献
1
Pharmacodynamic characteristics and influencing factors of tapentadol for chronic pain relief under dose titration.在剂量滴定下，曲马多用于缓解慢性疼痛的药效学特征及影响因素。
Front Pain Res (Lausanne). 2025 Jan 17;5:1474529. doi: 10.3389/fpain.2024.1474529. eCollection 2024.
2
BeHERE's effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings.BeHERE 的有效虚拟培训可增强在非物质使用障碍环境中支持药物使用者的能力。
Harm Reduct J. 2024 Feb 13;21(1):38. doi: 10.1186/s12954-024-00948-5.
3
"I'll Be Back": The Resurrection of Dezocine.“我会回来的”：地佐辛的复苏
ACS Med Chem Lett. 2021 May 19;12(6):961-968. doi: 10.1021/acsmedchemlett.1c00233. eCollection 2021 Jun 10.
4
Democratizing innovation through grass-roots entrepreneurship: lessons from efforts to address the opioid epidemic in the United States.通过基层创业实现创新民主化：美国应对阿片类药物流行努力的经验教训。
BMJ Glob Health. 2019 Dec 29;4(6):e002079. doi: 10.1136/bmjgh-2019-002079. eCollection 2019.
5
Opiate Prescribing Practices in the Postpartum Unit.产后病房的阿片类药物处方实践
Ochsner J. 2018 Spring;18(1):36-41.
本文引用的文献
1
Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.药物和阿片类药物滥用相关过量死亡人数增加 - 美国，2010-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1.
2
Failure to get into substance abuse treatment.未能接受药物滥用治疗。
J Subst Abuse Treat. 2017 Feb;73:55-62. doi: 10.1016/j.jsat.2016.11.004. Epub 2016 Nov 16.
Zotero 插件